No Detail Found!

Azithromycin inhibits the production of MUC5AC in the airway mucosa of patients with bronchiectasis induced by Pseudomonas aeruginosa

Author(s)
Junhui Wang Department of Pharmacy, The Affiliated Yantai Yuhuangding Hospital of Qingdao University,Yantai, Shandong, PR,China
Lei Xu Department of Pharmacy, The Affiliated Yantai Yuhuangding Hospital of Qingdao University,Yantai, Shandong, PR,China
Yanni Lv Department of Pharmacy, The Affiliated Yantai Yuhuangding Hospital of Qingdao University,Yantai, Shandong, PR,China
Lingfang Sun Department of Pharmacy, The Affiliated Yantai Yuhuangding Hospital of Qingdao University,Yantai, Shandong, PR,China
Abstract
To explore the clinical benefits of azithromycin in the treatment of Pseudomonas aeruginosa induced bronchiectasis and to evaluate its effect on MUC5AC. From April 2018 to June 2020, 160 patients with bronchiectasis due to Pseudomonas aeruginosa infection were selected. The patients were divided into a control groupand an azithromycin group. Statistics of patients' general clinical data, lung function indexes, sputum volume, oxidative stress level, Bhalla score before and after treatment; Western blot analysis of MUC5AC expression; RT-PCR analysis of TNF-a, IL-8, IL- 1ß mRNA expression. The mRNA expression of TNF-a, IL-8 and IL-1ß in the azithromycin group was lower than that in the control group (P<0.05). After treatment, the protein expression of MUC5AC in the azithromycin group was lower than that in the control group (P<0.05). The improvement rate in the azithromycin group was significantly higher than that in the control group (P<0.05). The azithromycin group had a lower lung infection rate than the control group (P<0.05). The azithromycin group had a lower dyspnea rate than the control group (P<0.05). Azithromycin treatment has certain clinical benefits for patients with bronchiectasis induced by Pseudomonas aeruginosa and inhibits the MUC5AC expression.
Publication Details
Page(s) 1179-1185
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: S3, Year: 2021

Request the full text from PASTIC

Keywords
Clinical trials, Bronchiectasis, Azithromycin, MUC5AC
References
Aizawa H,Koarai A,Shishikura Y,Yanagisawa S,Yamaya M,Sugiura H,Numakura T,Yamada M,Ichikawa T,Fujino N,Noda M,Okada Y,Ichinose M Y .2018 .Oxidative stress enhances the expression of IL-33 in human airway epithelial cells. Respir. Res., 19(1) : 52.
Boughton JM .2002 .The Bretton Woods proposal: A brief look. Polit. Sci. Q, 42(6) : 564.
Candice E Van Skike ,Jordan B Jahrling,Lechleiter and Veronica Galvan James D .2018 .Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. Am. J. Physiol. Heart Circ. Physiol., 314(4) : H693-H703.
Donghai W,Dai W .2018 .Metaanalysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis. Medicine, 98(17) : e15285.
Elizabeth S,Jaimin MP,Hannah G,Georgia MW,Frances G,Dhruv P,Rahul YM,Rachel CAD,Sebastian TL,Philip AH,Jon H,Paul N,Aaron S,Peter N,Adam TH,David RT TH .2019 .Simvastatin Improves Neutrophil Function and Clinical Outcomes in Pneumonia. A Pilot Randomized Controlled Clinical Trial. Am. J. Respir. Crit. Care Med, 200(10) : 1282-1293.
Soo-Jong Eun L,H Eun L .2019 .Pharmacotherapeutic strategies for treating bronchiectasis in pediatric patients. Expert Opin Pharmacother, 20(8) : 1025-1036.
Florian T,Trestan P,Antony C,Claire B,Angela K,Alban L,Gilbert G .2018 .Distinct Genomic Features Characterize Two Clades of Corynebacterium diphtheriae: Proposal of Corynebacterium diphtheriae Subsp. diphtheriae Subsp. nov. and Corynebacterium diphtheriae Subsp. Lausannense subsp. Nov. Front Microbiol.,, 9 : 1743.
Francesco B,Sarah W,Imai-Matsushima A,Gabriela S,Christian G,Monika S,Hilmar B,Morey P .2018 .Polarised epithelial monolayers of the gastric mucosa reveal insights into mucosal homeostasis and defence against infection. Gut, : 2017-314540.
Francesco M,Mirco L,Carla G,Gloria M,Alberto C,Nicola F .2018 .Heat-induced necrosis after bronchial thermoplasty: A new concern. Allergy Asthma Clin. Immunol, 14 : 25.
Gregory P,Benjamin H,Michael RJ,Kenneth O,Engelhardt TC,Keith MS,Noah J,John CG,Rohit B,Robert JK,Nilesh G,Kannan N,John R,Immad RS,Stephen KL,Narinder B,Raja ML,Barry SW,Fakhir FE,Mark JG,Mark K,Juan A,Peter S,William K,Ping-Yu L,Samuel ZG,Seattle II .2015 .Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. Investigators. A Prospective, 8(10) : 1382-1392.
Karam K,Hye JK,Bert B,Jin HK,Yup Chung Il HK .2018 .Inflammatory mediators ATP and S100A12 activate the NLRP3 inflammasome to induce MUC5AC production in airway epithelial cells. Biochem. Biophys. Res. Commun., 503(2) : 657-664.
Anne BC Keith G .2019 .A new dawn: Inhaled antibiotics for patients with bronchiectasis. Lancet Respir Med, 7(3) : 188-189.
Kimberly S,Paige C,Milena V,Kinner-Bibeau L,Shuang Hu,James C,Remling-Mulder L,Ken EO,Tawfik A,Ramesh A .2018 .Zika viral infection and neutralizing human antibody response in a BLT humanized mouse model. Virology, 515 : 235-242.
Martinez-García MA .2018 .Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: More questions than answers. Eur. Respir. J., 51(2) : 1702497.
Matthew JM,Helen L,Carly C,Kate P,Irshad S,Dominick ES,Tim WH .2019 .Idiopathic chronic productive cough and response to open-label macrolide therapy: An observational study. Respirology, 24(6) : 558-565.
Meng-Heng H,Chun-Yu L,Chen-Yu W,Yueh-Fu F,Shu-Min L,Horng-Chyuan L,L L .2018 .Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis. Infect Drug Resist, 11 : 1137-1143.
Navaratnam V,Douglas LF .2018 .Paediatric and adult bronchiectasis: Monitoring, cross-infection, role of multidisciplinary teams and self-management plans. Respirology, 24(2) : 115-126.
Padilla-Galo A,Olveira C,de Rota-Garcia LF,MarcoGalve I,Plata AJ,Alvarez A,Rivas-Ruiz F,CarmonaOlveira A,Cebrian-Gallardo JJ,Martinez-Garcia MA .2018 .Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: A study in 398 patients. Respir. Res., 19(1) : 43.
Pallavi B,Donald JD,Brian JM,Adriano GR,Adam TH .2018 .Blood Neutrophils are Reprogrammed in Bronchiectasis. Am J Respir Crit Care Med, 198(7) : 880-890.
Pieters A,Bakker M,Hoek RAS,Altenburg J,van Westreenen M,Aerts JGV,van der Eerden MM .2019 .The clinical impact of Pseudomonas aeruginosa eradication in bronchiectasis in a Dutch referral centre. Eur. Respir. J., 53(4) : 1802081.
Ranjana W,Billy S,Suzanna V,Rosemary C,Ranganathan S C .2019 .The role of geographical location and climate on recurrent Pseudomonas infection in young children with Cystic Fibrosis. J Cyst Fibros, 18(6) : 817-822.
Roland D,Santiago E,Stefan B,Christian J,Fabian J,Korfmann G,Sebastian S,Sivagurunathan S,Rademacher J .2019 .Incidence of patients with noncystic fibrosis bronchiectasis in Germany-A healthcare insurance claims data analysis. Respir Med, 151 : 121-127.
Sankalp M,Hayes D,Daniel JW .2019 .Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung. J. Cyst. Fibros, 18(6) : 796-803.
Stephanie E,Katrien L,Kristina V,Lieven JD,Bart MV,Janssens W .2018 .Aspergillus fumigatus Detection and Risk Factors in Patients with COPDBronchiectasis Overlap. Int. J. Mol. Sci, 19(2) : 523.
Suarez-Cuartin G,Jordi G,Merino JL,Rodrigo-Troyano A,Anna F,Lidia P,Sanchez-Reus F,Diego C,Vicente P,Chalmers JD,Oriol S JD .2018 .Identification of, Pseudomonas aeruginosa, and airway bacterial colonization by an electronic nose in bronchiectasis. Respir. Med, 136 : 111-117.
The-Thien T,Hong Yu,Celine V,Albert YHL,Abisheganaden JA,Chotirmall SH,Hadinoto K SH .2019 .An evaluation of inhaled antibiotic liposome versus antibiotic nanoplex in controlling infection in bronchiectasis. Int. J. Pharm., 559 : 382-392.
Tliba O,Panettieri RA .2019 .Paucigranulocytic asthma: Uncoupling of airway obstruction from inflammation. J Allergy Clin Immunol, 143(4) : 1287-1294.
Weronika G,Walencka M,Anthony PM,Krzysztof H,Obuchowski M,Magdalena C .2019 .Upregulation of MUC5AC production and deposition of LEWIS determinants by Helicobacter Pylori facilitate gastric tissue colonization and the maintenance of infection. J. Biomed. Sci., 26(1) : 23.
0

Citations

0

Downloads

11

Views